First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...
The FDA said it had rejected a cell therapy intended for patients with Duchenne muscular dystrophy developed by Capricor ...
Kennedy and MAHA say they aren’t anti-vaccine. They can prove it by promoting the MMR vaccine, writes Brinda Adhikari.
A graduate student who is a scientific researcher at Princeton was detained by ICE while traveling home after presenting ...
STAT reporters preview JPM 2027, sharing the trends, companies, rumors, and stories to watch at the J.P. Morgan Healthcare ...
Tax filings show the MAHA Institute spent more than $1 million in 2025, ending its first year with just $171,000 as events ...
Matthew Herper covers medical innovation — both its promise and its perils. Executives at Epic Systems Corp., the largest maker of electronic health records, said Wednesday they would make it easier ...
The National Academies urged the scientific community to respond more aggressively to claims of errors or manipulated data in ...
Sen. Bernie Sanders pushed back on assumptions that Trump would veto an expanded Medicare plan. “I am not absolutely certain ...
Medicare does not cover many of the lifestyle interventions that could keep people from getting sick in the first place.
Sanofi weighs an Insmed takeover, the FDA slams J&J over misleading bladder cancer drug claims, and more pharma news: ...
A monoclonal antibody holds promise in preventing malaria, but researchers found it interfered with a new vaccine when used ...